Alessandro Passardi

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 36

Top Venues

JMIR research protocols

International journal of molecular sciences

Cancers

JCO precision oncology

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Oct 01 2008

Italy

– Director of Day Hospital UNIT and oral antineoplastic drugs UNIT :: Medical Oncology Department

Ospedale Morgagni-Pierantoni

Italy

assistant oncology :: oncology department

Publications

Alessandro Passardi, Giorgia Marisi, Paola Ulivi
Metastatic Colorectal Cancer 2.0. Cancers 16 (12) (2024)
Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Stefano Tamberi, Federica Marmorino, Roberto Moretto, Michele Prisciandaro, Emiliano Tamburini, Giampaolo Tortora, Alessandro Passardi, Francesca Bergamo, Alessandra Raimondi, Giuliana Ritorto, Beatrice Borelli, Veronica Conca, Clara Ugolini, Giuseppe Aprile, Lorenzo Antonuzzo, Fabio Gelsomino, Erika Martinelli, Nicoletta Pella, Gianluca Masi, Luca Boni, Jerome Galon, Chiara Cremolini
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Francesco Giulio Sullo, Alessandro Passardi, Chiara Gallio, Chiara Molinari, Giorgia Marisi, Eleonora Pozzi, Leonardo Solaini, Alessandro Bittoni
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer. Journal of clinical medicine 13 (9) (2024)
Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio, Lisa Salvatore, Sara Lonardi, Stefano Tamberi, Federica Marmorino, Roberto Moretto, Michele Prisciandaro, Emiliano Tamburini, Giampaolo Tortora, Alessandro Passardi, Francesca Bergamo, Alessandra Raimondi, Giuliana Ritorto, Beatrice Borelli, Veronica Conca, Clara Ugolini, Giuseppe Aprile, Lorenzo Antonuzzo, Fabio Gelsomino, Erika Martinelli, Nicoletta Pella, Gianluca Masi, Luca Boni, Jerome Galon, Chiara Cremolini
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (22) (2024)
Alessandro Passardi, Giorgia Marisi, Paola Ulivi
Metastatic Colorectal Cancer 2.0. Cancers 16 (12) (2024)
Francesco Giulio Sullo, Alessandro Passardi, Chiara Gallio, Chiara Molinari, Giorgia Marisi, Eleonora Pozzi, Leonardo Solaini, Alessandro Bittoni
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer. Journal of clinical medicine 13 (9) (2024)
Elisabetta Petracci, Alessandro Passardi, Annibale Biggeri, Martina Valgiusti, Manlio Monti, Giovanni Luca Frassineti, Oriana Nanni, Emanuela Scarpi
Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial. JCO precision oncology 8 (2024)
Elisabetta Petracci, Alessandro Passardi, Annibale Biggeri, Martina Valgiusti, Manlio Monti, Giovanni Luca Frassineti, Oriana Nanni, Emanuela Scarpi
Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial. JCO precision oncology 8 (2024)
Elisabetta Petracci, Alessandro Passardi, Annibale Biggeri, Martina Valgiusti, Manlio Monti, Giovanni Luca Frassineti, Oriana Nanni, Emanuela Scarpi
Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial. JCO precision oncology 8 (2024)
Elisabetta Petracci, Alessandro Passardi, Annibale Biggeri, Martina Valgiusti, Manlio Monti, Giovanni Luca Frassineti, Oriana Nanni, Emanuela Scarpi
Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial. JCO precision oncology 8 (2024)
Joaquim C Reis, Luzia Travado, Alexander Scherrer, Thanos Kosmidis, Stefanos Venios, Paris Emmanouil Laras, Gabrielle Oestreicher, Markus Möhler, Margherita Parolini, Alessandro Passardi, Elena Meggiolaro, Giovanni Martinelli, Elisabetta Petracci, Chiara Zingaretti, Sotiris Diamantopoulos, Maria Plakia, Charalampos Vassiliou, Suheib Mousa, Robert Zifrid, Francesco Giulio Sullo, Chiara Gallio
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study. JMIR research protocols 12 (2023)
Laura Matteucci, Alessandro Bittoni, Graziana Gallo, Laura Ridolfi, Alessandro Passardi
Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era? Cancers 15 (21) (2023)
Joaquim C Reis, Luzia Travado, Alexander Scherrer, Thanos Kosmidis, Stefanos Venios, Paris Emmanouil Laras, Gabrielle Oestreicher, Markus Möhler, Margherita Parolini, Alessandro Passardi, Elena Meggiolaro, Giovanni Martinelli, Elisabetta Petracci, Chiara Zingaretti, Sotiris Diamantopoulos, Maria Plakia, Charalampos Vassiliou, Suheib Mousa, Robert Zifrid, Francesco Giulio Sullo, Chiara Gallio
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study. JMIR research protocols 12 (2023)
Valentina Fanotto, Daniele Rossini, Mariaelena Casagrande, Francesca Bergamo, Andrea Spagnoletti, Daniele Santini, Carlotta Antoniotti, Samanta Cupini, Francesca Daniel, Vincenzo Nasca, Guglielmo Vetere, Alberto Zaniboni, Beatrice Borelli, Martina Carullo, Veronica Conca, Alessandro Passardi, Emiliano Tamburini, Gianluca Masi, Nicoletta Pella, Chiara Cremolini
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies. Cancers 15 (22) (2023)
Carlotta Antoniotti, Alessandra Boccaccino, Robert S Seitz, Mirella Giordano, Aurelie Catteau, Daniele Rossini, Filippo Pietrantonio, Lisa Salvatore, Kimberly McGregor, Francesca Bergamo, Veronica Conca, Simone Leonetti, Federica Morano, Giorgio Papiani, Emiliano Tamburini, Maria Bensi, Sabina Murgioni, Douglas Teller Ross, Alessandro Passardi, Isabelle Boquet, Tyler J Nielsen, Jerome Galon, Matthew Gordon Varga, Brock L Schweitzer, Chiara Cremolini
An immune-related gene expression signature predicts benefit from adding atezolizumab to FOLFOXIRI plus bevacizumab in metastatic colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Alessandro Passardi, Irene Azzali, Alessandro Bittoni, Giorgia Marisi, Francesca Rebuzzi, Chiara Molinari, Giulia Bartolini, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Manlio Monti, Martina Valgiusti, Margherita Muratore, Ilario Giovanni Rapposelli, Paola Ulivi, Giovanni Luca Frassineti
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab. Therapeutic advances in medical oncology 15 (2023)
Alessandro Passardi, Irene Azzali, Alessandro Bittoni, Giorgia Marisi, Francesca Rebuzzi, Chiara Molinari, Giulia Bartolini, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Manlio Monti, Martina Valgiusti, Margherita Muratore, Ilario Giovanni Rapposelli, Paola Ulivi, Giovanni Luca Frassineti
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab. Therapeutic advances in medical oncology 15 (2023)
Alessandro Passardi, Emanuela Scarpi, Paola Ulivi
Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors. International journal of molecular sciences 24 (18) (2023)
Manlio Monti, Andrea Prochoswski Iamurri, David Bianchini, Chiara Gallio, Luca Esposito, Daniela Montanari, Silvia Ruscelli, Chiara Molinari, Flavia Foca, Alessandro Passardi, Giovanni Vittimberga, Paolo Morgagni, Giovanni Luca Frassineti
Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer. Nutrients 15 (16) (2023)
Joaquim C Reis, Luzia Travado, Alexander Scherrer, Thanos Kosmidis, Stefanos Venios, Paris Emmanouil Laras, Gabrielle Oestreicher, Markus Möhler, Margherita Parolini, Alessandro Passardi, Elena Meggiolaro, Giovanni Martinelli, Elisabetta Petracci, Chiara Zingaretti, Sotiris Diamantopoulos, Maria Plakia, Charalampos Vassiliou, Suheib Mousa, Robert Zifrid, Francesco Giulio Sullo, Chiara Gallio
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study. JMIR research protocols 12 (2023)
Joaquim C Reis, Luzia Travado, Alexander Scherrer, Thanos Kosmidis, Stefanos Venios, Paris Emmanouil Laras, Gabrielle Oestreicher, Markus Möhler, Margherita Parolini, Alessandro Passardi, Elena Meggiolaro, Giovanni Martinelli, Elisabetta Petracci, Chiara Zingaretti, Sotiris Diamantopoulos, Maria Plakia, Charalampos Vassiliou, Suheib Mousa, Robert Zifrid, Francesco Giulio Sullo, Chiara Gallio
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study. JMIR research protocols 12 (2023)
Joaquim C Reis, Luzia Travado, Alexander Scherrer, Thanos Kosmidis, Stefanos Venios, Paris Emmanouil Laras, Gabrielle Oestreicher, Markus Möhler, Margherita Parolini, Alessandro Passardi, Elena Meggiolaro, Giovanni Martinelli, Elisabetta Petracci, Chiara Zingaretti, Sotiris Diamantopoulos, Maria Plakia, Charalampos Vassiliou, Suheib Mousa, Robert Zifrid, Francesco Giulio Sullo, Chiara Gallio
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study. JMIR research protocols 12 (2023)
Joaquim C Reis, Luzia Travado, Alexander Scherrer, Thanos Kosmidis, Stefanos Venios, Paris Emmanouil Laras, Gabrielle Oestreicher, Markus Möhler, Margherita Parolini, Alessandro Passardi, Elena Meggiolaro, Giovanni Martinelli, Elisabetta Petracci, Chiara Zingaretti, Sotiris Diamantopoulos, Maria Plakia, Charalampos Vassiliou, Suheib Mousa, Robert Zifrid, Francesco Giulio Sullo, Chiara Gallio
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study. JMIR research protocols 12 (2023)
Alessandro Passardi, Flavia Foca, Orazio Caffo, Carlo Alberto Tondini, Alberto Zambelli, Roberto Vespignani, Giulia Bartolini, Francesco Giulio Sullo, Daniele Andreis, Marco Dianti, Claudio Eccher, Enrico Maria Piras, Stefano Forti
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial. Journal of medical Internet research 24 (1) (2022)
Alessandro Passardi, Patrizia Serra, Orazio Caffo, Carla Masini, Erika Brugugnoli, Roberto Vespignani, Valeria Giardino, Elisabetta Petracci, Giulia Bartolini, Francesco Sullo, Cecilia Anesi, Marco Dianti, Claudio Eccher, Enrico Maria Piras, Lorenzo Gios, Annalisa Campomori, Valentina Oberosler, Stefano Forti
Use of the ONCO-TreC electronic diary compared with a standard paper diary to improve adherence to oral cancer therapy in patients with solid and haematological tumours: protocol for a randomised controlled trial. BMJ open 12 (1) (2022)
Raffaella D'Onofrio, Chiara Santini, Stefano Cascinu, Krisida Cerma, Camilla Bardasi, Ingrid Garajovà, Elisabetta Lattanzi, Alessandro Passardi, Ilario Giovanni Rapposelli, Andrea Spallanzani, Massimiliano Salati, Luca Reggiani Bonetti, Roberta Gelmini, Bruno Meduri, Micaela Piccoli, Annarita Pecchi, Stefania Benatti, Francesco Giotta, Massimo Dominici, Gabriele Luppi, Fabio Gelsomino
Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience. Future oncology (London, England) 18 (24) (2022)
Ilario Giovanni Rapposelli, Stefano Cascinu, Caterina Vivaldi, Giulia Bartolini, Laura Bernardini, Alessandro Passardi, Giovanni Luca Frassineti, Valentina Massa, Alessandro Cucchetti
Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer. Biomolecules 11 (6) (2021)
Alessandro Passardi, Giorgia Marisi, Paola Ulivi
Metastatic Colorectal Cancer. Cancers 13 (24) (2021)
Alessandro Passardi, Patrizia Serra, Caterina Donati, Federica Fiori, Sabrina Prati, Roberto Vespignani, Gabriele Taglioni, Patrizia Farfaneti Ghetti, Giovanni Martinelli, Oriana Nanni, Mattia Altini, Giovanni Luca Frassineti, Martina Vittoria Minguzzi
An Integrated Model to Improve Medication Reconciliation in Oncology: Prospective Interventional Study. Journal of medical Internet research 23 (12) (2021)
Alessandro Passardi, Ilario Giovanni Rapposelli, Emanuela Scarpi, Francesco Giulio Sullo, Giulia Bartolini, Elisa Neri, Giulia Ghigi, Luca Tontini, Giorgio Ercolani, Manlio Monti, Silvia Ruscelli, Laura Matteucci, Martina Valgiusti, Giovanni Luca Frassineti, Antonino Romeo
Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies. Biomolecules 11 (8) (2021)
Alessandro Passardi, Emanuela Scarpi, Paola Ulivi
Special Issue on Molecular and Translational Research on Colorectal Cancer 2.0. International journal of molecular sciences 22 (14) (2021)
Alessandro Passardi, Emanuela Scarpi, Paola Ulivi
Molecular and Translational Research on Colorectal Cancer. International journal of molecular sciences 21 (11) (2020)
Francesca Pirini, Luigi Pasini, Gianluca Tedaldi, Emanuela Scarpi, Giorgia Marisi, Chiara Molinari, Daniele Calistri, Alessandro Passardi, Paola Ulivi
Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients. International journal of molecular sciences 21 (10) (2020)
Manlio Monti, Ilaria Massa, Flavia Foca, Paolo Morgagni, Massimo Framarini, Alessandro Passardi, Fabio Falcini, Giovanni Luca Frassineti
Retrospective analysis of gastric cancer management in a real-world setting: a single-institution experience. Tumori 106 (2) (2020)
Paola Ulivi, Emanuela Scarpi, Alessandro Passardi
Special Issue on Basic and Translational Research in Colorectal Cancer. International journal of molecular sciences 20 (12) (2019)
Chiara Molinari, Giorgia Marisi, Alessandro Passardi, Laura Matteucci, Giulia De Maio, Paola Ulivi
Heterogeneity in Colorectal Cancer: A Challenge for Personalized Medicine? International journal of molecular sciences 19 (12) (2018)

Alessandro Passardi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alessandro Passardi